CTLA4 and cancer: In cancer immunology research, IC molecules have garnered marked attention, particularly T cell-associated IC molecules such as programmed cell death ligand-1 (PD-L1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4), among others.